MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
Xtant Medical Holdings DPO Ratio 2011-2026 | XTNT
Annual DPO Ratio Xtant Medical Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.2 | 55.7 | 53.7 | 43.1 | 39.3 | 44.1 | 36 | 82.2 | 105 | 138 | 169 | 109 | 71.2 | 141 | 106 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 169 | 36 | 82.4 |
Quarterly DPO Ratio Xtant Medical Holdings
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57 | 62.1 | - | 59.5 | 57.2 | 62.3 | - | 46.2 | 46.2 | 42.6 | - | 26.3 | 18.3 | 45.5 | - | 34.6 | 42.9 | 55.7 | - | 56.4 | 67.6 | 45.4 | - | 37.6 | 37.2 | 66.8 | - | 103 | 94.2 | 126 | - | 101 | 108 | 126 | - | 134 | 141 | 132 | - | 142 | 254 | 174 | - | 117 | 108 | 88.9 | - | 76.1 | 70.7 | 98.9 | - | 140 | 157 | 163 | - | 184 | 139 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 254 | 18.3 | 91.7 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
52.3 | $ 3.72 | 0.95 % | $ 153 M |  USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.12 | 0.12 % | $ 872 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 36.6 | -0.44 % | $ 5.45 K | USA |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 62.34 | -0.76 % | $ 92.3 B | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 12.24 | 1.75 % | $ 1.65 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 9.37 | - | $ 265 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
CONMED Corporation
CNMD
|
57.3 | $ 34.21 | -1.67 % | $ 1.06 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.63 | 7.41 % | $ 39.2 M | USA |
 |
Delcath Systems
DCTH
|
56 | $ 9.76 | 1.35 % | $ 350 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.48 | 2.66 % | $ 130 M |  France |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 81.03 | -0.02 % | $ 47.4 B | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.59 | - | $ 122 M | USA |
 |
AxoGen
AXGN
|
34.4 | $ 32.72 | -4.99 % | $ 1.51 B | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 1.96 | 5.38 % | $ 1.19 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.3 | -2.41 % | $ 716 M | USA |
 |
Align Technology
ALGN
|
33.7 | $ 170.69 | 0.05 % | $ 12.8 B | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Inogen
INGN
|
34.6 | $ 6.41 | 3.22 % | $ 171 M | USA |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 0.99 | 1.0 % | $ 16.8 M | USA |
 |
IRadimed Corporation
IRMD
|
34.8 | $ 96.2 | -0.04 % | $ 1.22 B | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 84.91 | -2.23 % | $ 2.95 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.94 | -0.75 % | $ 374 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
LENSAR
LNSR
|
146 | $ 5.87 | -3.22 % | $ 70.2 M | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Pulmonx Corporation
LUNG
|
60.4 | $ 1.38 | 3.76 % | $ 56.1 M | USA |
 |
Medtronic PLC
MDT
|
76.2 | $ 86.52 | -0.13 % | $ 111 B | USA |
 |
MiMedx Group
MDXG
|
54.8 | $ 3.9 | -0.64 % | $ 576 M | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Myomo
MYO
|
34.8 | $ 0.69 | 2.43 % | $ 28.9 M | USA |